GlucoMe (גלוקומי)

Yarkona, Israel

GlucoMe is a digital health company developing and marketing a comprehensive digital solution for diabetes management. With its new algorithm-based Decision Support System analyzing relevant diabetes data and providing medical teams with treatment recommendations, GlucoMe is on track to realizing its vision of offering an autonomous diabetes health care platform. The GlucoMe solution enables smart and cost-effective remote care and monitoring, streamlining and simplifying diabetes care for patients, caregivers and medical professionals. The platform integrates individual patient and population management, designed to efficiently increase engagement and compliance. Its core architecture enables quick and simple implementation and allows organizations to easily scale up while delivering quality care. The GlucoMe platform includes an affordable wireless blood glucose monitor that operates with unique patented audio connectivity; a mobile app compatible with iOS and Android devices; a Digital Diabetes Clinic - a cloud-based diabetes monitoring and control management software for healthcare organizations and professionals; and a Control Tower, which enables patient and population data-driven prioritization and management. For additional information about GlucoMe visit www.glucome.com and follow the company on LinkedIn and Facebook.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out GlucoMe (גלוקומי) on @MedStartr Today #Diabetes #Type2Diabetes #Type1Diabetes #CardiometabolicConditions #MedMo #MedStartrVentures

https://www.medstartr.ai/s/VDdpaJgfScE

Get Involved in GlucoMe (גלוקומי)

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2012
Website: www.glucome.com

Disease Areas

Diabetes Type 2 Diabetes Type 1 Diabetes Cardiometabolic Conditions

Technologies

Diabetes ManagementDecision SupportAI/Machine LearningDigital Health Platforms

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of GlucoMe (גלוקומי)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.